New York Daily News

Share

New York Daily News

 •  December 11

In the midst of a national opioid crisis, the federal agency that monitors drug ads has issued a record low number of warning letters to pharmaceutical companies caught lying about their products. The Food and Drug Administration has sent a mere three letters to drugmakers busted for overhyping their medications to unknowing consumers, the lowest...

New York Daily News

 •  August 31

For those facing the agony, they may soon get to have the ecstasy. The FDA has designated the drug ecstasy a "breakthrough" in conjunction with psychotherapy for PTSD treatment. The special status will allow the closely monitored combination of therapy and the drug, clinically known as MDMA, to get through clinical trials faster. Working with the...

New York Daily News

 •  August 31

The drug is marketed as a treatment for the most common types of childhood cancers but its price tag puts it widely out of reach for most people. The first cancer drug approved by U.S. regulators to use a patient's own cells to fight common childhood cancers is priced at a whopping $475,000. "Kymriah," the name of the cancer-fighter, was created by...

New York Daily News

 •  August 14

By Kane Wu HONG KONG (Reuters) - A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co <601607.SS> are among bidders for a stake in U.S. speciality drugmaker Arbor Pharmaceuticals LLC, the companies said on Monday. The bids come as Chinese companies face tightening scrutiny on their overseas investments. Chinese regulators are...

New York Daily News

 •  July 31

Your cigarette addiction may soon go up in smoke. The Food and Drug Administration announced Friday that it wants to lower the nicotine levels in cigarettes to “non-addictive” levels. More than 35 million people smoke in the United States — an all-time low of 15% of the population — and more than 480,000 die from it, statistics show. Victims don’t...

New York Daily News

 •  July 28

(Reuters) - Merck & Co Inc said the international cyber attack it suffered in June halted some of its manufacturing and other operations and cut its profit forecast for the year. The drugmaker said, while announcing its second quarter-earnings on Friday, that it is in the process of restoring its manufacturing operations and does not yet know the...

New York Daily News

 •  July 27

Amid reports of rising prescription drug abuse by city students, NYPD officials are mulling a plan to outfit school safety agents drugs to reverse opioid overdoses. Assistant Chief Brian Conroy first revealed development to Staten Island school board president Michael Reilly in an email Monday night, after Reilly wrote him about a Daily News cover...

New York Daily News

 •  July 21

By Ben Hirschler LONDON (Reuters) - AstraZeneca Chief Executive Pascal Soriot, responding to rumors he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work together with employees to see the company succeed. A company spokeswoman added he was intending to attend the European Society for Medical...

New York Daily News

 •  July 14

By Kate Holton and Paul Sandle LONDON (Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca said on Friday its chief executive, Pascal Soriot, would host a results call with reporters on July 27, after refusing to comment on speculation this week that he was leaving the firm. An report on Wednesday on Israeli financial news website Calcalist...

New York Daily News

 •  July 1

By Ben Hirschler LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday. Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring...